Track the Newbury Pharmaceuticals AB stock price and the full insider trade history of the company, a publicly traded company based in Finland. Shares are listed on the FI market, under the authority of FIN-FSA. Operating in the Health Care sector, Newbury Pharmaceuticals AB has logged 3 public disclosures. Market capitalisation: €76m. The latest transaction was filed on 18 November 2025 (Purchase). Among the most active insiders: Alsakali Equity AB. The full history is free.
3
Insider Decl.
n/a
Thresholds
€13,711
3 ops.
Buy Volume
n/a
n/a
Sell Volume
33Σ signal
Buys €13,711n/a Sells
Fundamental score
Ranked 27,305 of 29,063 companies
17.2
score / 100
Value
11
Quality
23
FCF yld-18%
Earn yld-19%
EV/EBITDA·
ROE-67%
Gross mgn44%
Net mgn-42%
Debt/EBITDA·
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.